Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Deletion/duplication mutation screening of TP53 gene in patients with transitional cell carcinoma of urinary bladder using multiplex ligation-dependent probe amplification.

Bazrafshani MR, Nowshadi PA, Shirian S, Daneshbod Y, Nabipour F, Mokhtari M, Hosseini F, Dehghan S, Saeedzadeh A, Mosayebi Z.

Cancer Med. 2016 Feb;5(2):145-52. doi: 10.1002/cam4.561. Epub 2015 Dec 21.

2.

GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy.

Deng X, Yang X, Cheng Y, Liu X, Li X, Zhao R, Qin C, Lu Q, Yin C.

Sci Rep. 2015 Sep 10;5:14000. doi: 10.1038/srep14000.

3.

Bladder papillary urothelial neoplasm of low malignant potential in Chinese: a clinical and pathological analysis.

Zhang XK, Wang YY, Chen JW, Qin T.

Int J Clin Exp Pathol. 2015 May 1;8(5):5549-55. eCollection 2015.

4.

Role of morphometry and proliferative parameters in grading of urothelial neoplasms.

Sangwan M, Singh S, Kumar S, Chabbra S, Sen R, Rana P, Malik S, Singh S, Lamba R.

Cent European J Urol. 2015;68(1):37-44. doi: 10.5173/ceju.2015.01.447. Epub 2015 Mar 13.

5.

Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.

Maxwell JP, Wang C, Wiebe N, Yilmaz A, Trpkov K.

Diagn Pathol. 2015 Mar 13;10:3. doi: 10.1186/s13000-015-0234-z.

6.

Relationship of PCNA, C-erbB2 and CD44s expression with tumor grade and stage in urothelial carcinomas of the bladder.

Yıldırım A, Kösem M, Sayar I, Gelincik I, Yavuz A, Bozkurt A, Erkorkmaz U, Bayram I.

Int J Clin Exp Med. 2014 Jun 15;7(6):1516-23. eCollection 2014.

7.

TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.

Kinde I, Munari E, Faraj SF, Hruban RH, Schoenberg M, Bivalacqua T, Allaf M, Springer S, Wang Y, Diaz LA Jr, Kinzler KW, Vogelstein B, Papadopoulos N, Netto GJ.

Cancer Res. 2013 Dec 15;73(24):7162-7. doi: 10.1158/0008-5472.CAN-13-2498. Epub 2013 Oct 11.

8.

Profile of lesions in cystoscopic bladder biopsies: a histopathological study.

Srikousthubha, Sukesh, C V R, Hingle S.

J Clin Diagn Res. 2013 Aug;7(8):1609-12. doi: 10.7860/JCDR/2013/5166.3233. Epub 2013 Aug 1.

9.

Prospective evaluation of interobserver diagnostic agreement for focal urinary bladder wall abnormalities detected by ultrasound.

Francica G, Scarano F, Bellini SA, Miragliuolo A.

J Ultrasound. 2011 Mar;14(1):1-6. doi: 10.1016/j.jus.2010.11.002. Epub 2010 Dec 3.

10.

The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer.

Chen Z, Ding W, Xu K, Tan J, Sun C, Gou Y, Tong S, Xia G, Fang Z, Ding Q.

PLoS One. 2012;7(10):e47199. doi: 10.1371/journal.pone.0047199. Epub 2012 Oct 17.

11.

Urothelial bladder carcinoma in young patients is characterized by a relatively good prognosis.

Poletajew S, Walędziak M, Fus Ł, Pomada P, Ciechańska J, Wasiutyński A.

Ups J Med Sci. 2012 Mar;117(1):47-51. doi: 10.3109/03009734.2011.650797. Epub 2012 Jan 30.

12.

Reproductibilité des classifications OMS 1973 et OMS 2004 des tumeurs urothéliales papillaires de la vessie.

Ben Abdelkrim S, Rammeh S, Trabelsi A, Ben Yacoub-Abid L, Ben Sorba N, Jaïdane L, Mokni M.

Can Urol Assoc J. 2012 Dec;6(6):E230-3. doi: 10.5489/cuaj.10078. Epub 2011 Sep 8.

13.

Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States.

Schned AR, Andrew AS, Marsit CJ, Kelsey KT, Zens MS, Karagas MR.

Scand J Urol Nephrol. 2008;42(3):237-42. doi: 10.1080/00365590801948166.

14.

Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies.

Montironi R, Lopez-Beltran A, Mazzucchelli R, Bostwick DG.

J Clin Pathol. 2003 Feb;56(2):91-5. Review.

Supplemental Content

Support Center